ERG is a transcription factor, which becomes expressed as a result of a gene fusion involving the androgen-regulated gene TMPRSS2 and the ERG locus in about 50% of prostate cancers [7, 43, 44]. Here, TMPRSS2 is linked to prostate carcinoma.